A novel multi-biomarker combination predicting relapse from long-term remission after discontinuation of biological drugs in rheumatoid arthritis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel multi-biomarker combination predicting relapse from long-term remission after discontinuation of biological drugs in rheumatoid arthritis
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-10-21
DOI
10.1038/s41598-021-00357-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prediction of disease flare by biomarkers after discontinuing biologics in patients with rheumatoid arthritis achieving stringent remission
- (2021) Hideto Kameda et al. Scientific Reports
- Effect of IL-34 on T helper 17 cell proliferation and IL-17 secretion by peripheral blood mononuclear cells from rheumatoid arthritis patients
- (2020) Xin Li et al. Scientific Reports
- Interleukin-34 as a promising clinical biomarker and therapeutic target for inflammatory arthritis
- (2019) Wanvisa Udomsinprasert et al. CYTOKINE & GROWTH FACTOR REVIEWS
- IL-2 production by self-reactive CD4 thymocytes scales regulatory T cell generation in the thymus
- (2019) Saskia Hemmers et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis
- (2018) Jasmine Chong et al. NUCLEIC ACIDS RESEARCH
- Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment
- (2018) Marjan Ghiti Moghadam et al. PLoS One
- Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010
- (2018) Kunihiro Ichinose et al. Journal of Immunology Research
- STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets
- (2018) Damian Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Wide difference in biologics usage and expenditure for the treatment of patients with rheumatoid arthritis in each prefecture in Japan analyzed using “National Database of Health Insurance Claims and Specific Health Checkups of Japan”
- (2017) Yasuyuki Kamata et al. RHEUMATOLOGY INTERNATIONAL
- Functions of interleukin-34 and its emerging association with rheumatoid arthritis
- (2016) Ren-Peng Zhou et al. IMMUNOLOGY
- Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study
- (2015) Judith Haschka et al. ANNALS OF THE RHEUMATIC DISEASES
- Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment
- (2015) Juergen Rech et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment
- (2014) Aude I. Ségaliny et al. INTERNATIONAL JOURNAL OF CANCER
- Bone- and Cartilage-Protective Effects of a Monoclonal Antibody Against Colony-Stimulating Factor 1 Receptor in Experimental Arthritis
- (2014) Myew-Ling Toh et al. Arthritis & Rheumatology
- Increased Levels of Interleukin 34 in Serum and Synovial Fluid Are Associated with Rheumatoid Factor and Anticyclic Citrullinated Peptide Antibody Titers in Patients with Rheumatoid Arthritis
- (2013) S.-J. Moon et al. JOURNAL OF RHEUMATOLOGY
- IL-34 Induces the Differentiation of Human Monocytes into Immunosuppressive Macrophages. Antagonistic Effects of GM-CSF and IFNγ
- (2013) Etienne D. Foucher et al. PLoS One
- Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis
- (2013) Michael Centola et al. PLoS One
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics
- (2012) Y Kanda BONE MARROW TRANSPLANTATION
- Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity
- (2012) Jeffrey R. Curtis et al. ARTHRITIS CARE & RESEARCH
- Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients
- (2011) M Chemel et al. ANNALS OF THE RHEUMATIC DISEASES
- American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
- (2011) D. T. Felson et al. ANNALS OF THE RHEUMATIC DISEASES
- Consensus Substrate Sequence for Protein-tyrosine Phosphatase Receptor Type Z
- (2011) Akihiro Fujikawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interleukin-19 blockade attenuates collagen-induced arthritis in rats
- (2011) Y.-H. Hsu et al. RHEUMATOLOGY
- Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood
- (2010) Hiroyuki Eda et al. CYTOKINE
- Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis
- (2010) Marc Baud'Huin et al. JOURNAL OF PATHOLOGY
- The Japanese experience with biologic therapies for rheumatoid arthritis
- (2010) Tsutomu Takeuchi et al. Nature Reviews Rheumatology
- Expression of IL-10 family cytokines in rheumatoid arthritis: elevated levels of IL-19 in the joints
- (2009) T Alanärä et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now